Open-Label Extension of Pimavanserin for Agitation and Aggression in Alzheimer's

Source: https://www.nia.nih.gov/alzheimers/clinical-trials/open-label-extension-pimavanserin-agitation-and-aggression-alzheimers


Undefined

Purpose: To evaluate the safety and tolerability of pimavanserin (Nuplazid™) as a treatment for agitation and aggression in adults with probable Alzheimer's disease .

…

Source: https://www.nia.nih.gov/alzheimers/clinical-trials/open-label-extension-pimavanserin-agitation-and-aggression-alzheimers


Undefined

Purpose: To evaluate the safety and tolerability of pimavanserin (Nuplazid™) as a treatment for agitation and aggression in adults with probable Alzheimer's disease .

…

What Do You Think?

comments

Translate »